Guardant Health, Inc. vs Eli Lilly & Co.
GH vs LLY — side-by-side comparison from reported financials. GH leads 1, LLY leads 7 of 8 comparable metrics.
Guardant Health, Inc.
GH · Healthcare
$167.40+1.11%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | GH | LLY |
|---|---|---|
| Price | $167.40 | $1 177.20 |
| Market cap | $22.5B | $1.05T |
| Revenue (TTM) | $1.18B | $79.7B |
| Revenue growth | +29.8% | +31.7% |
| Net margin | -38.3% | 33.5% |
| Free cash flow | -$241M | $18.2B |
| Net cash (debt) | — | ($35.2B) |
| 1-year price return | +156.5% | +37.6% |
| P/E | — | 41.6 |
| P/E vs own history (cheap-side %) | — | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | -247% | 93% |
| Altman Z-score | 4.47 | 7.10 |
| CV checks passed | 5 of 9 | 11 of 9 |
| Employees | 2,506 | 50,000 |
Full résumé-style profiles: GH CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.